Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.7%

10 terminated/withdrawn out of 589 trials

Success Rate

90.8%

+4.3% vs industry average

Late-Stage Pipeline

14%

83 trials in Phase 3/4

Results Transparency

3%

3 of 99 completed trials have results

Key Signals

165 recruiting3 with results9 withdrawn

Enrollment Performance

Analytics

N/A
133(34.6%)
Phase 2
85(22.1%)
Phase 1
58(15.1%)
Phase 3
45(11.7%)
Phase 4
38(9.9%)
Early Phase 1
25(6.5%)
384Total
N/A(133)
Phase 2(85)
Phase 1(58)
Phase 3(45)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (589)

Showing 20 of 589 trials
NCT04078568Phase 3Completed

Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease

Role: collaborator

NCT07533994Recruiting

ACOD1 as a Prognostic Marker for Sepsis

Role: lead

NCT07533825Not ApplicableEnrolling By Invitation

Laparoscopic Staging for Stage III Gastric Cancer

Role: collaborator

NCT07532122Completed

Postoperative Anxiety and Depression Among Chinese Elderly Patients

Role: collaborator

NCT06970262Not ApplicableRecruiting

FMT for Lung and Associated-organ Rescue Efficacy in ARDS Patients

Role: lead

NCT07521124Not ApplicableNot Yet Recruiting

ABC Maintenance Therapy for AML

Role: lead

NCT07520123Not ApplicableNot Yet Recruiting

Union-FAST: An Intelligent-Agent Intervention to Increase Antiviral Treatment Uptake in Diagnosed-but-Untreated Hepatitis B Patients

Role: lead

NCT07506447Completed

The Value of [18F]FDG PET/CT Imaging in Prognostic Evaluation of Mucosal Melanoma

Role: lead

NCT06603883Phase 2Completed

Efficacy of Fecal Microbiota Transplantation in ICU Patients With Gastrointestinal Dysfunction-induced Enteral Nutrition Intolerance

Role: lead

NCT07497243Not Yet Recruiting

X-ray Assisted Diagnostic System

Role: lead

NCT07498673Early Phase 1Not Yet Recruiting

A Study of YKST02 in Participants With Primary IgA Nephropathy

Role: lead

NCT06836869Not ApplicableRecruiting

Modified Tumor-free Techniques Operation to Cervical Cancer

Role: collaborator

NCT07485764Phase 4Not Yet Recruiting

Metformin Combined With Secukinumab for Moderate-to-Severe Plaque Psoriasis in Overweight or Obese Chinese Patients

Role: lead

NCT07404891Not ApplicableRecruiting

Clinical Trial on the Efficacy and Safety of ALT001 in Osteoarthritis

Role: lead

NCT07113769Recruiting

Plasma Biomarkers and Platelet Morphology of Extracorporeal CardioPulmonary Resuscitation

Role: collaborator

NCT06124404Phase 2Completed

Step 1 of A Two-step Trial to Evaluate the Effectiveness and Safety of Remimazolam Besylate for Sedation in ICU Patients

Role: lead

NCT05042245Phase 4Completed

The Efficacy and Safety of Ornithine Aspartic Acid Granules in NAFLD Against Silymarin Capsules

Role: collaborator

NCT07474103Not ApplicableRecruiting

SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC

Role: lead

NCT07209787Phase 4Recruiting

SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak

Role: collaborator

NCT07470073Early Phase 1Recruiting

A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Kinetics of Universal Car-t Cell Injection in CD19 and / or CD20 Positive Relapsed / Refractory B-cell Acute Lymphoblastic Leukemia in Adolescents, Children and Adults

Role: lead